Expression and partial biochemical characterization of a recombinant serine protease from Bothrops pauloensis snake venom

Snake venom serine proteases (SVSPs) are enzymes capable of interfering at several points of hemostasis. Some serine proteases present thrombin-like activity, which makes them targets for the development of therapeutics agents in the treatment of many hemostatic disorders. In this study, a recombina...

Full description

Saved in:
Bibliographic Details
Published in:Toxicon (Oxford) Vol. 115; pp. 49 - 54
Main Authors: Isabel, Thais F., Costa, Guilherme Nunes Moreira, Pacheco, Isabela B., Barbosa, Luana G., Santos-Junior, Célio D., Fonseca, Fernando P.P., Boldrini França, Johara, Henrique-Silva, Flávio, Yoneyama, Kelly A.G., Rodrigues, Renata S., Rodrigues, Veridiana de Melo
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-06-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Snake venom serine proteases (SVSPs) are enzymes capable of interfering at several points of hemostasis. Some serine proteases present thrombin-like activity, which makes them targets for the development of therapeutics agents in the treatment of many hemostatic disorders. In this study, a recombinant thrombin-like serine protease, denominated rBpSP-II, was obtained from cDNA of the Bothrops pauloensis venom gland and was characterized enzymatically and biochemically. The enzyme rBpSP-II showed clotting activity on bovine plasma and proteolytic activity on fibrinogen, cleaving exclusively the Aα chain. The evaluation of rBpSP-II activity on chromogenic substrates demonstrated thrombin-like activity of the enzyme due to its capacity to hydrolyze the thrombin substrate. These characteristics make rBpSP-II an attractive molecule for additional studies. Further research is needed to verify whether rBpSP-II can serve as a template for the synthesis of therapeutic agents to treat hemostatic disorders. •rBpSP-II showed sequence identity ranging from 83% to 96% to other snake venom serine proteases.•rBpSP-II showed activity on chromogenic substrates demonstrated thrombin-like activity.•rBpSP-II can serve as template for synthesis of therapeutic agents to treat hemostatic disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-0101
1879-3150
DOI:10.1016/j.toxicon.2016.03.002